| 2024年年报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 分部间抵销(元) | - | - | -1,093,395,000.00 |
| 医药商业贸易(元) | - | - | 1,773,448,100.00 |
| 医药制造业(元) | - | - | 1,137,463,900.00 |
| 医药行业(元) | 2,799,986,300.00 | 3,128,091,300.00 | - |
| 营业成本(元) | |||
| 分部间抵销(元) | - | - | -1,117,782,600.00 |
| 医药商业贸易(元) | - | - | 650,104,000.00 |
| 医药制造业(元) | - | - | 543,108,200.00 |
| 医药行业(元) | 159,301,000.00 | 152,341,700.00 | - |
| 毛利(元) | |||
| 分部间抵销(元) | - | - | 24,387,600.00 |
| 医药商业贸易(元) | - | - | 1,123,344,100.00 |
| 医药制造业(元) | - | - | 594,355,700.00 |
| 医药行业(元) | 2,640,685,300.00 | 2,975,749,600.00 | - |
| 毛利率(%) | |||
| 分部间抵销(%) | - | - | -2.23 |
| 医药商业贸易(%) | - | - | 63.34 |
| 医药制造业(%) | - | - | 52.25 |
| 医药行业(%) | 94.31 | 95.13 | - |
| 收入构成(%) | |||
| 分部间抵销(%) | - | - | -60.16 |
| 医药商业贸易(%) | - | - | 97.58 |
| 医药制造业(%) | - | - | 62.58 |
| 医药行业(%) | 100.00 | 100.00 | - |
| 毛利构成(%) | |||
| 分部间抵销(%) | - | - | 1.40 |
| 医药商业贸易(%) | - | - | 64.48 |
| 医药制造业(%) | - | - | 34.12 |
| 医药行业(%) | 100.00 | 100.00 | - |